UK Public Sector Contracts & Tenders

This is an updated notice and replaces Notice Number 2025/S 000-08731 and Notice Reference 2025-0410587due to these services being impacted by the community MSK and pain service procurement. This is a change to the original notification The Contract Term is to reduce uncertainty for the Providers and to ensure continuity of service. Originally the award was approved by Executive Committee in November 2024 as an award for 7 months with an option to extend for 5 months. The Contract Term shall now be for 12 months, with a 3 months’ notice period. The current procurement timeline is indicating a new service may start on 1st February 2026, but this is subject to change. A Community Carpal Tunnel Decompression service for adults that supports the appropriate management of Carpal Tunnel Syndrome in the community and reduces the number of referrals to the acute unless complex decompression procedure is necessary. This ensures that decompression surgery is only provided when conservative treatment has failed to reduce symptoms. There is a need for an urgent award of contracts for Community Carpal Tunnel Decompression service for adults for a period of 12 months from the 1st April 2025 to the 31st March 2026) to ensure sufficient time for the procurement and that there is no risk to patient safety through increased (long) waiting times unless an arrangement is in place for 1 April 2025 as all access would then be referred into MSEFT who have confirmed they cannot absorb the activity within current capacity. The current contract with the incumbent (Provide Wellbeing Limited) expires on 31st March 2025 and as a consequence there is a requirement to award this contract. The value is a £0 value contract – paid at local prices – planning value for 2025-26 is £337,527.

The ICB has experienced a number of practices serving notice on the prescribing of Adult ADHD medication (and are following suit on paediatric ADHD medication prescribing). The intention was that these patients would return to the specialist service that prescribed the medication originally in order to get their ongoing care. However, in the medium term it is apparent that those service providers will not be able to scale up at pace to meet the increased demand. As an interim solution we will commission ADHD Shared Care Prescribing Service to Thrive Health Hubs Trading as Thurrock Health Hubs to deliver the service from 15th June 2025 to 31st March 2026. The indicative value of the contract is £20,000 for the period. The award is being made urgently in order to provide continuity of care. There is significant risk that if this award was not made there would be an impact on this cohort of patients to their health. The reason for the urgency was not foreseeable by and is not attributable to the relevant authority and delaying the award to conduct a full application of the PSR would be likely to pose a risk to patient or public safety. The urgent provision is to an existing provider who holds contracts on behalf of the ICB and has been recently assessed for other contracts which provides assurance to the capability and capacity to deliver the services required over the next ten months whilst a longer terms solution is developed.

This is a Contract Award notice following publication of a voluntary ex ante transparency notice to provide notice of NHS Mid and South Essex Integrated Care Board ("the ICB") intention to award a 12-month contract term, (1st July 2023 - 30th June 2024) with the option to extend the contract by up to an additional 12-month period (1st July 2024-30th June 2025 for the provision of Corporate IT Service Management across Mid and South Essex.

This is a contract award notice following publication of a voluntary ex ante transparency notice which expired at 12:00 midnight on 3rd January 2023 and is intended to provide notice of NHS Mid and South Essex Integrated Care Board ("the ICB") intention to award a 24-month contract term, with the option to extend the contract for up to an additional 12-month period, for the provision of Primary Care (GP) IT Service Management and Primary Care Enabling Services for Primary Care, Pharmacists, Optometrists and Dentists (PODs) across Mid and South Essex.

NHS Mid and South Essex Integrated Care Board (ICB) have awarded a contract to Attain Health Management Services Ltd for provision of project management consultancy services to support the ICB's data migration of GP IT data from an unsupported server to a NHSE 'Cloud based' server. This was a compliant award under the East of England Collaborative Procurement Hub (EoECPH) framework for Transforming Organisations, Partnerships & Systems - Multi- Specialty Support & Advisory Consultancy Services.

Following a compliant negotiated procedure without prior publication, the Authority has made a decision to award a contract to KIDS for the design, development, digitisation and pilot implementation of two psychoeducational resources, across Essex, Southend, and Thurrock. These will be evidence-based therapeutic interventions, that provide information and support to better understand and cope with autism for CYP and for parents and carers of CYP, following diagnosis. The contract commences 23rd January 2023, expiring 31st March 2026, at an aggregate value of £398,000.

The contracting authority, NHS Mid and South Essex Integrated Care Board (the Authority) is undertaking an urgent award for provision of Enteral Feeds to the existing provider in mid and south Essex, in accordance with Schedule 5, Paragraph 13(1)(b) - Additional or repeat goods, services or works, under the Procurement Act 2023. The scope of the requirement covers feeds and plastics delivered to patients' homes, off script as well as a nursing and patient support service. Travel service, staff and family training pre and post hospital discharge are also included. The proposed aggregate contract value is £4,340,533 for the 12 month duration. The proposed contract duration is 1st April 2026 - 31st March 2027.

The contracting authority, NHS Mid and South Essex Integrated Care Board (the Authority) is undertaking an urgent award for provision of Enteral Feeds to the existing provider in mid and south Essex, in accordance with Schedule 5, Paragraph 13(1)(b) - Additional or repeat goods, services or works, under the Procurement Act 2023. The scope of the requirement covers feeds and plastics delivered to patients' homes, off script as well as a nursing and patient support service. Travel service, staff and family training pre and post hospital discharge are also included. The proposed aggregate contract value is £4,340,533 for the 12 month duration. The proposed contract duration is 1st April 2026 - 31st March 2027.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board ("the ICB") intention to award a 12-month contract term, with the option to extend the contract for up to an additional 12-month period, for the provision of Corporate IT Service Management across Mid and South Essex.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board ("the ICB") intention to award a 24-month contract term, with the option to extend the contract for up to an additional 12-month period, for the provision of Primary Care (GP) IT Service Management and Primary Care Enabling Services for Primary Care, Pharmacists, Optometrists and Dentists (PODs) across Mid and South Essex.

The Authority invited responses on 16 September 2022 (Notice reference: 2022/S 000-026063), from suitably qualified and experienced providers to deliver Autism Spectrum Disorder (ASD) Post-Diagnostic Psychoeducational Resource for Parents/Carers and Young People in Greater Essex("the Service") from 19th December 2022 to 18th December 2025.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver the provision of Admission Prevention & Early Discharge Service (APED) service for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 1st April 2025 - 31st March 2026 . The aggregate contract value is forecasted at £359,034.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S XXXX) on the XX December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,027,687.

The Prescribing Decision Support Tool enables prescribers (GPs, nurses and pharmacists) to understand the recommended local choices for prescribing. The implementation of this system creates significant savings through prescribers accepting the recommended switches and also educates prescribers to select those first choice products the next time these are prescribed. The tool also provides safety messages at the point of prescribing. A contract to deliver the Prescribing Decision Support Tool across the Mid and South Essex Integrated Care Board (MSE ICB) area has been awarded to Optum. This contract has been awarded via the SBS Framework for Medicines Management Prescribing Decision Support Systems 2 (Reference SBS/19/AB/WAS/9389). This contract commences 1st September 2022 for a period of 24 months until the 31st August 2024, with the option to extend the contract for a further 12 months. The total aggregate contract value is £1,210,140.00 (inclusive of VAT).The total aggregate contract value is £1,008,450.00 (excluding VAT) and this figure has been reflected in the award notice published by the Authority in line with Find a Tender Service publishing guidance.

The Contracting Authority (hereinafter referred to as "the Authority") for this procurement was NHS Mid and South Essex Integrated Care Board (ICB). On the 6th October 2022, the Authority invited responses from suitably qualified and experienced providers (via publication of a Contract Notice in FTS, reference 2022-043094) to deliver Primary Medical Services across up to six Lots, via Alternative Provider of Medical Services (APMS) contract(s) for a period of 15 years. Contracts for Lots 1 to 4 and Lot 6 will run from 01/04/23 - 31/03/38, and the contract for Lot 5 will run from 01/07/23 - 30/06/38. The aggregate value (forecasted financial entitlement) of the contract across all 6 Lots is £91,153,559, including up to £25,000 Allowable Mobilisation Budget on a cost incurred basis, per Lot, in Year 1). (The financial entitlement across all six Lots, minus the allowable mobilisation budget is £91,003,559). The Lots: • Lot 1 - Y00999 - Oddfellows Health Centre & St Clements Health Centre - commencing 1st April 2023 until 31st March 2038 • Lot 2 - F81110 - Tilbury Health Centre - commencing 1st April 2023 until 31st March 2038 • Lot 3 - Y02807 - Thurrock Health Centre - commencing 1st April 2023 until 31st March 2038 • Lot 4 - F81206 - Commonwealth Health Centre - commencing 1st April 2023 until 31st March 2038 • Lot 5 - Y00033 - Purfleet Care Centre - commencing 1st July 2023 until 30th June 2038 • Lot 6 - F81684 - North Shoebury Surgery - commencing 1st April 2023 until 31st March 2038 The Authority has procured all six lots as APMS contracts due to the time limited nature of them and flexibilities that they permit in terms of bidding audience e.g. whole of the market and the ability to agree the reporting schedules enabling KPIs that support delivery of the Long-term Plan and facilitates and enables the development of "at scale" provision through the PCN model of delivery. In line with the strategic aims for Mid & South Essex ICB, the system is committed to deliver primary care on a standard contract term to allow for delivery at scale and innovation by offering longer term arrangements. As such, each contract has been awarded for a period of 15 years to give greater certainty for provider to improve value for money, ability to recruit, willingness to invest time and resources. We want to secure the right fit for the specific needs of that population. The contract that is being entered into by the Authority and the Preferred Bidder will be governed by the Standard Alternative Provider of Medical Services (APMS) Contract.

There is a need for an urgent award of contracts for Personal Health Budget Direct Payment Support Service to provide a Payroll and Managed Accounts Service to all individuals and their representatives/carers referred by the ICB or its partners and providers covering all aspects of receiving and managing a Personal Health Budget. A Managed Account is where all an individual's Direct Health Payment is paid to the Managed Account Service Provider who fulfills the function of processing invoices and making payments on behalf of an individual and according to the individual's support plan. This is for a period of 12 months from the 13th November 2025 to the 12th November 2026 as there is no time as the current incumbent provider has gone into administration unexpectedly, leaving no time to use a more detailed process to procure another provider, as patients care and safety needs to be protected by securing an immediate stand in provider. Attain have advised that an urgent award would be appropriate for a short-term agreement. The incumbent provider has become insolvent, leaving 19 patients without a package of care, there is an urgent need to protect the health of these patients. The reason for the urgency was not foreseeable by and is not attributable to the relevant authority and delaying the award to conduct a full application of the PA23 would be likely to pose a risk to patient or public safety. Patients will be at risk of not having their care supported if their personal health budgets are not managed effectively and this could result in withdrawal of care packages, without notice The reason for the urgency was not foreseeable by and is not attributable to the relevant authority and delaying the award to conduct a full application of the PA23 would be likely to pose a risk to patient or public safety. NHS Contract for the provision of services recommended for use. The current contract with the incumbent expired on 12th November 2025 and the proposed contract value is £18,388.00 (Involves fixed and variable costs. £18,388 calculated based on activity to date)

This VEAT was published in error.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (lead Commissioner) and NHS Suffolk and North East Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver the management of infectious diseases outbreaks within Care Homes to the patients and staff working within these Care Homes within Mid and South Essex', Suffolk and North East Essex's geographical footprint. The contract will be for 3 year period with the option to extend for a further 24 months, from 01st April 2024 - 31st March 2029 including all extensions. The aggregate contract value including all extensions is forecasted at £900,00.00

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,027,687.